CGTX Aligns Pivotal Study
Cognition Therapeutics aligns on key aspects of pivotal study for Zervimesine in DLB psychosis after receiving FDA meeting minutes
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.